The U.S. Food and Drug Administration is set to give the Pfizer COVID-19 vaccine an emergency use authorization for children age 12-15, according to reports, after its trial results showed similar efficacy among that age group compared to adults. It comes as some states like New York will allow shops, restaurants and other businesses will be allowed to operate at full capacity starting May 19.
- Pfizer sees ‘durable demand’ for COVID-19 vaccine as it boosts sales forecast
- U.S. FDA expected to approve Pfizer COVID-19 vaccine for children 12 to 15 by next week